263 related articles for article (PubMed ID: 26175929)
1. Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.
Chen TC; Fonseca CO; Schönthal AH
Am J Cancer Res; 2015; 5(5):1580-93. PubMed ID: 26175929
[TBL] [Abstract][Full Text] [Related]
2. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.
Chen TC; da Fonseca CO; Levin D; Schönthal AH
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959448
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
8. Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas.
da Fonseca CO; Khandelia H; Salazar MD; Schönthal AH; Meireles OC; Quirico-Santos T
Surg Neurol Int; 2016; 7():1. PubMed ID: 26862440
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of perillyl alcohol and its metabolite perillic acid in plasma and lung after inhalational administration in Wistar rats.
de Lima DC; Rodrigues SV; Boaventura GT; Cho HY; Chen TC; Schönthal AH; Da Fonseca CO
Drug Test Anal; 2020 Feb; 12(2):268-279. PubMed ID: 31800149
[TBL] [Abstract][Full Text] [Related]
10. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells.
Chan NL; Wang H; Wang Y; Leung HY; Leung LK
Toxicol Appl Pharmacol; 2006 Jun; 213(2):98-104. PubMed ID: 16307765
[TBL] [Abstract][Full Text] [Related]
11. A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
Bailey HH; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Simon K; Marnocha R; Holstein SA; Stewart J; Lewis KA; Hohl RJ
Cancer Chemother Pharmacol; 2004 Oct; 54(4):368-76. PubMed ID: 15205914
[TBL] [Abstract][Full Text] [Related]
12. Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats.
Nehra G; Andrews S; Rettig J; Gould MN; Haag JD; Howard SP; Thorne RG
Sci Rep; 2021 Mar; 11(1):6351. PubMed ID: 33737566
[TBL] [Abstract][Full Text] [Related]
13. Development of a perillyl alcohol topical cream formulation.
Gupta A; Myrdal PB
Int J Pharm; 2004 Jan; 269(2):373-83. PubMed ID: 14706249
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy.
Santos JG; Faria G; Cruz WDCSD; Fontes CA; Schönthal AH; Quirico-Santos T; da Fonseca CO
Surg Neurol Int; 2020; 11():389. PubMed ID: 33282452
[TBL] [Abstract][Full Text] [Related]
15. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
16. Perillyl Alcohol (Monoterpene Alcohol), Limonene.
Shojaei S; Kiumarsi A; Moghadam AR; Alizadeh J; Marzban H; Ghavami S
Enzymes; 2014; 36():7-32. PubMed ID: 27102697
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the Antiproliferative Activity of Perillyl Alcohol against Glioblastoma Cell Lines through Synergistic Formulation with Natural Oils.
Alharbi WS; Alshehri AA; Ahmed TA; Md S; Almehmady AM; Alshabibi MA; Altamimi RM; El-Say KM
Curr Pharm Des; 2024 Mar; ():. PubMed ID: 38532602
[TBL] [Abstract][Full Text] [Related]
18. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trial of perillyl alcohol administered daily.
Ripple GH; Gould MN; Stewart JA; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Pomplun M; Wilding G; Bailey HH
Clin Cancer Res; 1998 May; 4(5):1159-64. PubMed ID: 9607573
[TBL] [Abstract][Full Text] [Related]
20. Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
Liston BW; Nines R; Carlton PS; Gupta A; Aziz R; Frankel W; Stoner GD
Cancer Res; 2003 May; 63(10):2399-403. PubMed ID: 12750258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
